Dr. Reddy's Laboratories share news, announcements and annual reports
NSE: DRREDDYBSE: 500124Pharmaceuticals & BiotechnologyMid Cap
Dr. Reddy's Laboratories Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1986 on BSE, May 2003 on NSE
Last close ₹1,310.00down ₹0.90 (0.07%)BSE ₹1,305.00
Share price at the NSE close on 27 Oct 2026. Previous close ₹1,310.90.
27 Oct: open ₹1,309.00, high ₹1,323.70, low ₹1,299.40
52-week range of traded prices to 27 Oct 2026
₹1,101.00Low, 23 Jul 2026₹1,414.90High, 29 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,09,343 Cr104th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 39.05
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.82
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.61%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 6.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.15
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 22,01,00247.3% delivered
Dr. Reddy's Laboratories has 1,701 announcements on record, routine notices left out; 10 in the 30 days to 28 Oct 2026, the latest on 24 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Dr. Reddy's Laboratories quarterly results
Oct23Fri
The board met on 23 Oct 2026 to consider financial results
Notice filed 22 Sep 2026
To consider and approve the financial results for the period ended September 30, 2026
Dr. Reddy's Laboratories annual reports, presentations and earnings calls
The company's own documents, latest first.Dr. Reddy's Laboratories financials, year by year
Annual reports17
- Annual report, year to Mar 202630 Jun 2026
- Annual report, year to Mar 202530 Jun 2025
- Annual report, year to Mar 20242 Jul 2024
- Annual report, year to Mar 20231 Jul 2023, a zip file
- Annual report, year to Mar 20226 Sep 2022, a zip file
12 earlier reports
- Annual report, year to Mar 20212 Jul 2021, a zip file
- Annual report, year to Mar 20206 Jul 2020, a zip file
- Annual report, year to Mar 20194 Jul 2019, a zip file
- Annual report, year to Mar 20187 Aug 2018, a zip file
- Annual report, year to Mar 201731 Jul 2017, a zip file
- Annual report, year to Mar 201628 Jul 2016, a zip file
- Annual report, year to Mar 20156 Jul 2015, a zip file
- Annual report, year to Mar 20147 Jul 2014, a zip file
- Annual report, year to Mar 201316 Jul 2013, a zip file
- Annual report, year to Mar 20126 Jul 2012, a zip file
- Annual report, year to Mar 201115 Jul 2011, a zip file
- Annual report, year to Mar 201020 Aug 2010, a zip file
Investor presentations8
- Dr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentation23 Oct 2026
- Dr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentation22 Jul 2026
- Dr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentation12 May 2026
- Dr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentation21 Jan 2026
- Dr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentation24 Oct 2025
3 earlier presentations
Earnings calls44
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording24 Oct 2026
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript28 Jul 2026
- Intimation of Earnings call recordings23 Jul 2026
- Dr. Reddy's Laboratories Limited has informed the Exchange about Conference call Transcript15 Jul 2026
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording10 Jul 2026
39 earlier call documents
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript18 May 2026
- Recording of Earnings call12 May 2026
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript27 Jan 2026
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording21 Jan 2026
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript30 Oct 2025
- Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Earnings call recordings'.25 Oct 2025
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript29 Jul 2025
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording23 Jul 2025
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript15 May 2025
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording10 May 2025
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript29 Jan 2025
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording24 Jan 2025
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript11 Nov 2024
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording5 Nov 2024
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript1 Aug 2024
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording27 Jul 2024
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript2 Jul 2024
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording27 Jun 2024
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript13 May 2024
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording8 May 2024
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript5 Feb 2024
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording31 Jan 2024
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript1 Nov 2023
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording28 Oct 2023
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript of Earnings call for Q1 FY2431 Jul 2023
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording26 Jul 2023
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript15 May 2023
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording11 May 2023
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript30 Jan 2023
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording26 Jan 2023
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call3 Nov 2022
- Dr. Reddy's Laboratories Limited has informed the Exchange about Recording of Analysts/Institutional Investor Meet/Con. Call29 Oct 2022
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call3 Aug 2022
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call28 Jun 2022
- Dr. Reddy's Laboratories Limited has informed the Exchange about transcript of earnings call held on May 19, 202224 May 2022
- Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation on earnings call transcript and audio'.1 Feb 2022
- Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript5 Nov 2021
- Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording29 Oct 2021
- Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy of the earnings call transcript for Q3-FY16.17 Feb 2016, a zip file
Dr. Reddy's Laboratories merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings8
- Dr. Reddy's Laboratories Limited has informed the Exchange about Effective date for Scheme of Merger8 Apr 2022
- Dr. Reddy's Laboratories Limited has informed the Exchange about record date for allotment of shares pursuant to scheme for Merger8 Apr 2022
- Dr. Reddy's Laboratories Limited has informed the Exchange about NCLT Approval of the Scheme of Amalgamationand Arrangement7 Apr 2022
- Dr. Reddy's Laboratories Limited has informed the Exchange about Newspaper publication and notice for NCLT convened unsecured creditors meeting2 Dec 2019
- Dr. Reddy's Laboratories Limited has informed the Exchange about Newspaper publication and notice for NCLT convened equity shareholder meeting2 Dec 2019
3 earlier filings
- Dr. Reddy's Laboratories Limited has informed the Exchange about Amalgamation/Merger25 Nov 2019
- Dr. Reddy's Laboratories Limited has informed the Exchange about Amalgamation/Merger29 Jul 2019
- Dr. Reddy'S Laboratories Limited has informed the Exchange that pursuant to an order dated April 21, 2010, passed by the Hon'ble High Court of Andhra Pradesh in the Company Application (Dr. Reddy's Laboratories Limited), a meeting of the members of Dr. Reddy's Laboratories Limited, the Applicant abovenamed, is being convened for the purpose of considering and, if thought fit, approving, with or without modification, the proposed scheme of arrangement between Dr. Reddy's Laboratories Limited and its members for the issue of unsecured, redeemable, non-convertible, fully paid up bonus debentures of Dr. Reddy's Laboratories Limited from its general reserve, under sections 391 to 394 of the Companies Act, 1956 (hereinafter referred to as the "Scheme").17 May 2010, a zip file
Dr. Reddy's Laboratories share news and announcements
Newest first. Page 1 of 35.
Oct 2026
23 Oct · General Updates
14 Oct · General Updates
8 Oct · General Updates
Sep 2026
22 Sep · Board meeting
18 Sep · Arrangements for strategic, technical, manufacturing, or marketing tie up
11 Sep · General Updates
Aug 2026
14 Aug · General Updates
14 Aug · General Updates
7 Aug · General Updates
Jul 2026
29 Jul · General Updates
29 Jul · News Verification
The exchange asked on 28 Jul 2026
9 Jul · General Updates
Jun 2026
25 Jun · General Updates
1 Jun · Analysts
May 2026
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 26 Oct 2026Resultsup 6.62%+5.8 pts vs Nifty 500market median −0.7% · volume 4.6× usual · delivery −26.2 pts against usual · The announcement
- 26 Oct 2026Board or managers changedup 6.62%+5.8 pts vs Nifty 500market median 0.0% · volume 4.6× usual · delivery −26.2 pts against usual · The announcement
- 14 Aug 2026Board or managers changeddown 0.50%−0.2 pts vs Nifty 500market median 0.0% · five sessions −2.2% (−1.5 pts vs Nifty 500) · volume 0.9× usual · delivery +10.6 pts against usual · The announcement
- 23 Jul 2026Resultsdown 1.40%−0.7 pts vs Nifty 500market median −0.7% · five sessions −3.4% (−4.3 pts vs Nifty 500) · volume 2.4× usual · delivery −13.9 pts against usual · The announcement
- 23 Jul 2026Board or managers changeddown 1.40%−0.7 pts vs Nifty 500market median 0.0% · five sessions −3.4% (−4.3 pts vs Nifty 500) · volume 2.4× usual · delivery −13.9 pts against usual · The announcement
- 13 May 2026Resultsdown 0.37%−0.7 pts vs Nifty 500market median −0.7% · five sessions +5.1% (+4.1 pts vs Nifty 500) · volume 3.1× usual · delivery −9.0 pts against usual · The announcement
- 11 Mar 2026Board or managers changedup 0.83%+2.2 pts vs Nifty 500market median 0.0% · five sessions −2.3% (+0.7 pts vs Nifty 500) · volume 1.7× usual · delivery +7.7 pts against usual · The announcement
- 10 Feb 2026Board or managers changeddown 1.53%−1.8 pts vs Nifty 500market median 0.0% · five sessions −0.5% (+0.4 pts vs Nifty 500) · volume 0.7× usual · delivery +3.1 pts against usual · The announcement
- 22 Jan 2026Resultsup 5.21%+4.5 pts vs Nifty 500market median −0.7% · five sessions +4.5% (+3.2 pts vs Nifty 500) · volume 4.7× usual · delivery −10.4 pts against usual · The announcement
- 11 Nov 2025Board or managers changedup 1.07%+0.7 pts vs Nifty 500market median 0.0% · five sessions +3.8% (+2.3 pts vs Nifty 500) · volume 0.5× usual · delivery −4.2 pts against usual · The announcement
20 earlier announcements
- 27 Oct 2025Resultsup 0.05%−0.6 pts vs Nifty 500market median −0.7% · five sessions −6.7% (−6.8 pts vs Nifty 500) · volume 1.0× usual · delivery −10.6 pts against usual · The announcement
- 2 Sep 2025Board or managers changeddown 2.05%−2.1 pts vs Nifty 500market median 0.0% · five sessions −2.3% (−3.0 pts vs Nifty 500) · volume 1.1× usual · delivery +0.8 pts against usual · The announcement
- 24 Jul 2025Resultsup 1.45%+2.0 pts vs Nifty 500market median −0.7% · five sessions +3.6% (+5.3 pts vs Nifty 500) · volume 2.8× usual · delivery −28.2 pts against usual · The announcement
- 12 May 2025Resultsup 3.43%−0.4 pts vs Nifty 500market median −0.7% · five sessions +6.5% (+1.0 pts vs Nifty 500) · volume 2.3× usual · delivery −23.0 pts against usual · The announcement
- 12 May 2025Dividendup 3.43%−0.4 pts vs Nifty 500market median 0.0% · five sessions +6.5% (+1.0 pts vs Nifty 500) · volume 2.3× usual · delivery −23.0 pts against usual · The announcement
- 12 May 2025Board or managers changedup 3.43%−0.4 pts vs Nifty 500market median 0.0% · five sessions +6.5% (+1.0 pts vs Nifty 500) · volume 2.3× usual · delivery −23.0 pts against usual · The announcement
- 30 Dec 2024Credit ratingdown 0.90%−0.5 pts vs Nifty 500market median 0.0% · five sessions −2.6% (−3.8 pts vs Nifty 500) · volume 0.9× usual · delivery +3.9 pts against usual · The announcement
- 21 Nov 2024Credit ratingdown 1.49%−0.7 pts vs Nifty 500market median 0.0% · five sessions −1.1% (−4.2 pts vs Nifty 500) · volume 1.5× usual · delivery −24.3 pts against usual · The announcement
- 6 Nov 2024Resultsup 2.35%+0.8 pts vs Nifty 500market median −0.7% · five sessions −0.7% (+0.9 pts vs Nifty 500) · volume 5.6× usual · delivery −15.5 pts against usual · The announcement
- 29 Jul 2024Resultsdown 0.56%−1.0 pts vs Nifty 500market median −0.7% · five sessions +1.2% (+1.4 pts vs Nifty 500) · volume 1.5× usual · delivery −5.4 pts against usual · The announcement
- 6 Jun 2024Credit ratingup 1.15%−0.3 pts vs Nifty 500market median 0.0% · five sessions +4.1% (−0.3 pts vs Nifty 500) · volume 1.4× usual · delivery −1.8 pts against usual · The announcement
- 8 May 2024Resultsdown 3.22%−3.5 pts vs Nifty 500market median −0.7% · five sessions −6.2% (−6.4 pts vs Nifty 500) · volume 2.5× usual · delivery −21.4 pts against usual · The announcement
- 8 May 2024Dividenddown 3.22%−3.5 pts vs Nifty 500market median 0.0% · five sessions −6.2% (−6.4 pts vs Nifty 500) · volume 2.5× usual · delivery −21.4 pts against usual · The announcement
- 8 May 2024Board or managers changeddown 3.22%−3.5 pts vs Nifty 500market median 0.0% · five sessions −6.2% (−6.4 pts vs Nifty 500) · volume 2.5× usual · delivery −21.4 pts against usual · The announcement
- 25 Apr 2024Board or managers changedup 4.50%+3.8 pts vs Nifty 500market median 0.0% · five sessions +5.7% (+4.0 pts vs Nifty 500) · volume 2.8× usual · delivery −9.1 pts against usual · The announcement
- 31 Jan 2024Resultsup 4.80%+3.6 pts vs Nifty 500market median −0.7% · five sessions +5.6% (+3.2 pts vs Nifty 500) · volume 4.2× usual · delivery −26.4 pts against usual · The announcement
- 11 Jan 2024Board or managers changeddown 1.64%−2.0 pts vs Nifty 500market median 0.0% · five sessions −2.4% (−2.2 pts vs Nifty 500) · volume 1.5× usual · delivery −3.9 pts against usual · The announcement
- 27 Oct 2023Resultsdown 0.45%−1.7 pts vs Nifty 500market median −0.7% · five sessions −1.5% (−3.6 pts vs Nifty 500) · volume 1.1× usual · delivery −3.5 pts against usual · The announcement
- 27 Jul 2023Resultsup 0.57%+0.9 pts vs Nifty 500market median −0.7% · five sessions +3.4% (+4.1 pts vs Nifty 500) · volume 3.6× usual · delivery −17.8 pts against usual · The announcement
- 11 May 2023Dividenddown 6.89%−7.0 pts vs Nifty 500market median 0.0% · five sessions −7.9% (−7.7 pts vs Nifty 500) · volume 8.5× usual · delivery −13.7 pts against usual · The announcement
Dr. Reddy's Laboratories results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.